Effect of polyfluoroalkyl chemicals on the occurrence of urge urinary incontinence: a population-based study

1. Komesu, YM, Amundsen, CL, Richter, HE, et al. Refractory urgency urinary incontinence treatment in women: impact of age on outcomes and complications. Am J Obstet Gynecol 2018; 218: 111.e1–111.e9.
Google Scholar | Crossref2. Aoki, Y, Brown, HW, Brubaker, L, et al. Urinary incontinence in women. Nat Rev Dis Primers 2017; 3: 17042.
Google Scholar | Crossref | Medline3. Hartmann, KE, McPheeters, ML, Biller, DH, et al. Treatment of overactive bladder in women. Evid Rep Technol Assess (Full Rep) 2009; 187: 1–120, v.
Google Scholar4. Coyne, KS, Wein, A, Nicholson, S, et al. Economic burden of urgency urinary incontinence in the United States: a systematic review. J Manag Care Pharm 2014; 20: 130–140.
Google Scholar | Crossref | Medline5. Varella, LRD, Bezerra da Silva, R, Eugênia de Oliveira, MC, et al. Assessment of lower urinary tract symptoms in different stages of menopause. J Phys Ther Sci 2016; 28: 3116–3121.
Google Scholar | Crossref | Medline6. Biswas, B, Bhattacharyya, A, Dasgupta, A, et al. Urinary incontinence, its risk factors, and quality of life: a study among women aged 50 years and above in a rural health facility of West Bengal. J Midlife Health 2017; 8: 130–136.
Google Scholar | Medline7. Huang, M, Jiao, J, Zhuang, P, et al. Serum polyfluoroalkyl chemicals are associated with risk of cardiovascular diseases in national US population. Environ Int 2018; 119: 37–46.
Google Scholar | Crossref | Medline8. Jian, J-M, Chen, D, Han, F-J, et al. A short review on human exposure to and tissue distribution of per- and polyfluoroalkyl substances (PFASs). Sci Total Environ 2018; 636: 1058–1069.
Google Scholar | Crossref | Medline9. Kvalem, HE, Nygaard, UC, Lødrup Carlsen, KC, et al. Perfluoroalkyl substances, airways infections, allergy and asthma related health outcomes - implications of gender, exposure period and study design. Environ Int 2020; 134: 105259.
Google Scholar | Crossref | Medline10. Mao, W, Hu, Q, Chen, S, et al. Polyfluoroalkyl chemicals and the risk of kidney stones in US adults: a population-based study. Ecotoxicol Environ Saf 2021; 208: 111497.
Google Scholar | Crossref | Medline11. Spratlen, MJ, Perera, FP, Lederman, SA, et al. The association between prenatal exposure to perfluoroalkyl substances and childhood neurodevelopment. Environ Pollut 2020; 263: 114444.
Google Scholar | Crossref | Medline12. Zhang, S, Tan, R, Pan, R, et al. Association of perfluoroalkyl and polyfluoroalkyl substances with premature ovarian insufficiency in Chinese women. J Clin Endocrinol Metab 2018; 103: 2543–2551.
Google Scholar | Crossref | Medline13. Lau, C, Anitole, K, Hodes, C, et al. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007; 99: 366–394.
Google Scholar | Crossref | Medline | ISI14. Centers for Disease Control and Prevention . National health and nutrition examination survey. Hyattsville, MD: Centers for Disease Control and Prevention, 2013.
Google Scholar15. Weinberg, AE, Leppert, JT, Elliott, CS. Biochemical measures of diabetes are not independent predictors of urinary incontinence in women. J Urol 2015; 194: 1668–1674.
Google Scholar | Crossref | Medline16. Pearce, MM, Zilliox, MJ, Rosenfeld, AB, et al. The female urinary microbiome in urgency urinary incontinence. Am J Obstet Gynecol 2015; 213: 347.e1–11.
Google Scholar | Crossref | Medline17. Liu, J, Mejia Avendaño, S. Microbial degradation of polyfluoroalkyl chemicals in the environment: a review. Environ Int 2013; 61: 98–114.
Google Scholar | Crossref | Medline18. Blake, BE, Fenton, SE. Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: a review including the placenta as a target tissue and possible driver of peri- and postnatal effects. Toxicology 2020; 443: 152565.
Google Scholar | Crossref | Medline19. Buck, RC, Franklin, J, Berger, U, et al. Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integr Environ Assess Manag 2011; 7: 513–541.
Google Scholar | Crossref | Medline20. Prevedouros, K, Cousins, IT, Buck, RC, et al. Sources, fate and transport of perfluorocarboxylates. Environ Sci Technol 2006; 40: 32–44.
Google Scholar | Crossref | Medline21. Haug, LS, Thomsen, C, Becher, G. Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. Environ Sci Technol 2009; 43: 2131–2136.
Google Scholar | Crossref | Medline22. Stanifer, JW, Stapleton, HM, Souma, T, et al. Perfluorinated chemicals as emerging environmental threats to kidney health: a scoping review. Clin J Am Soc Nephrol 2018; 13: 1479–1492.
Google Scholar | Crossref | Medline23. Dhingra, R, Lally, C, Darrow, LA, et al. Perfluorooctanoic acid and chronic kidney disease: longitudinal analysis of a Mid-Ohio valley community. Environ Res 2016; 145: 85–92.
Google Scholar | Crossref | Medline24. Watkins, DJ, Josson, J, Elston, B, et al. Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant. Environ Health Perspect 2013; 121: 625–630.
Google Scholar | Crossref | Medline25. Marcelissen, T, Anding, R, Averbeck, M, et al. Exploring the relation between obesity and urinary incontinence: Pathophysiology, clinical implications, and the effect of weight reduction, ICI-RS 2018. Neurourol Urodyn 2019; 38: S18–S24.
Google Scholar | Crossref | Medline26. Traini, C, Del Popolo, G, Faussone-Pellegrini, M-S, et al. Nerve sprouting and neurogenic inflammation characterize the neurogenic detrusor overactive bladder of patients no longer responsive to drug therapies. J Cell Mol Med 2019; 23: 4076–4087.
Google Scholar | Crossref | Medline27. Sant, KE, Sinno, PP, Jacobs, HM, et al. Nrf2a modulates the embryonic antioxidant response to perfluorooctanesulfonic acid (PFOS) in the zebrafish, Danio rerio. Aquat Toxicol 2018; 198: 92–102.
Google Scholar | Crossref | Medline28. Chou, H-C, Wen, L-L, Chang, C-C, et al. From the cover: l-Carnitine via PPARγ- and Sirt1-dependent mechanisms attenuates epithelial-mesenchymal transition and renal fibrosis caused by perfluorooctanesulfonate. Toxicol Sci 2017; 160: 217–229.
Google Scholar | Crossref | Medline29. Lu, Y, Gao, K, Li, X, et al. Mass spectrometry-based metabolomics reveals occupational exposure to per- and polyfluoroalkyl substances relates to oxidative stress, fatty acid β-oxidation disorder, and kidney injury in a manufactory in China. Environ Sci Technol 2019; 53: 9800–9809.
Google Scholar | Crossref | Medline30. Flohé, L, Brigelius-Flohé, R, Saliou, C, et al. Redox regulation of NF-kappa B activation. Free Radic Biol Med 1997; 22: 1115–1126.
Google Scholar | Crossref | Medline | ISI31. Lee, J, Koo, N, Min, DB. Reactive oxygen species, aging, and antioxidative nutraceuticals. Compr Rev Food Sci Food Saf 2004; 3: 21–33.
Google Scholar | Crossref | Medline | ISI

留言 (0)

沒有登入
gif